Report cover image

Atherosclerosis Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Aug 25, 2024
Length 121 Pages
SKU # PROD19315907

Description

Atherosclerosis Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global atherosclerosis drugs market is expected to grow at a CAGR of around 2.5% during 2025-2034. This report on global atherosclerosis drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global atherosclerosis drugs market by segmenting the market based on type, route of administration, distribution channel and region. Also, detailed profiles of companies operating in the atherosclerosis drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Awareness about Cardiovascular Diseases

Market Challenges

• Low Diagnostic Rate

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

• Anti-platelet and Anticoagulants
• Cholesterol Lowering Medication
• ACE Inhibitors
• Beta Blockers
• Other Drug Types

Market by Route of Administration

• Oral
• Injectable

Market by Route of Administration

• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies

Market by Distribution Channel

• Consumer Electronics
• Healthcare
• Aerospace and Defense
• Telecommunication
• Other Distribution Channels

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

121 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Atherosclerosis Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Atherosclerosis Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Type
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Atherosclerosis Drugs Market by Type
5.1. Introduction
5.2. Anti-platelet and Anticoagulants
5.3. Cholesterol Lowering Medication
5.4. ACE Inhibitors
5.5. Beta Blockers
5.6. Other Drug Types
6. Global Atherosclerosis Drugs Market by Route of Administration
6.1. Introduction
6.2. Oral
6.3. Injectable
7. Global Atherosclerosis Drugs Market by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Providers
7.4. Drug Stores and Retail Pharmacies
8. Global Atherosclerosis Drugs Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Amgen Inc.
12.2.2. AstraZeneca
12.2.3. Bausch Health Companies Inc.
12.2.4. Bayer AG
12.2.5. Eli Lilly and Company
12.2.6. GlaxoSmithKline Plc
12.2.7. Johnson & Johnson
12.2.8. Lupin
12.2.9. Merck & Co., Inc.
12.2.10. Novartis AG
12.2.11. Pfizer Inc.
12.2.12. Regeneron Pharmaceuticals, Inc.
12.2.13. Sanofi
12.2.14. Viatris (Mylan N.V.)
List of Figures
Figure 1: Global Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 2: Global Atherosclerosis Drugs Market by Type, 2024
Figure 3: Global Atherosclerosis Drugs Market by Route of Administration, 2024
Figure 4: Global Atherosclerosis Drugs Market by Distribution Channel, 2024
Figure 5: Global Atherosclerosis Drugs Market by Region, 2024
Figure 6: Global Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 7: Global Atherosclerosis Drugs Market by Type (in %), 2024 & 2034
Figure 8: Global Anti-platelet and Anticoagulants Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 9: Global Anti-platelet and Anticoagulants Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 10: Global Cholesterol Lowering Medication Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 11: Global Cholesterol Lowering Medication Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 12: Global ACE Inhibitors Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 13: Global ACE Inhibitors Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 14: Global Beta Blockers Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 15: Global Beta Blockers Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 16: Global Other Drug Types Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 17: Global Other Drug Types Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 18: Global Atherosclerosis Drugs Market by Route of Administration (in %), 2024 & 2034
Figure 19: Global Oral Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 20: Global Oral Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 21: Global Injectable Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 22: Global Injectable Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 23: Global Atherosclerosis Drugs Market by Distribution Channel (in %), 2024 & 2034
Figure 24: Global Hospital Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 25: Global Hospital Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 26: Global Online Providers Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 27: Global Online Providers Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 28: Global Drug Stores and Retail Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 29: Global Drug Stores and Retail Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 30: Global Atherosclerosis Drugs Market by Region (in %), 2024 & 2034
Figure 31: Europe Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 32: Europe Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 33: Europe Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
Figure 34: Germany Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 35: United Kingdom Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 36: France Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 37: Italy Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 38: Spain Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 39: Russia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 40: Netherlands Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 41: North America Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 42: North America Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 43: North America Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
Figure 44: United States Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 45: Canada Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 46: Asia Pacific Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 47: Asia Pacific Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 48: Asia Pacific Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
Figure 49: China Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 50: Japan Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 51: India Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 52: South Korea Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 53: Australia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 54: Indonesia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 55: Latin America Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 56: Latin America Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 57: Latin America Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
Figure 58: Mexico Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 59: Brazil Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 60: Argentina Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 61: Middle East & Africa Atherosclerosis Drugs Market (in US$ Million), 2020-2024
Figure 62: Middle East & Africa Atherosclerosis Drugs Market (in US$ Million), 2025-2034
Figure 63: Middle East & Africa Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
Figure 64: Saudi Arabia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 65: Turkey Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 66: Iran Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 67: UAE Atherosclerosis Drugs Market (in US$ Million), 2020-2034
Figure 68: Market Value Chain
List of Tables
Table 1: Global Atherosclerosis Drugs Market Portraiture
Table 2: Global Atherosclerosis Drugs Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Atherosclerosis Drugs Market by Route of Administration (in US$ Million), 2024 & 2034
Table 4: Global Atherosclerosis Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 5: Global Atherosclerosis Drugs Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Atherosclerosis Drugs Market by Country (in US$ Million),
2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us